Accelerate Diagnostics Files 8-K on Financials
| Field | Detail |
|---|---|
| Company | Accelerate Diagnostics, Inc |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: AXDX
TL;DR
AXDX filed an 8-K on 3/21/25 detailing financial condition and results.
AI Summary
Accelerate Diagnostics, Inc. filed an 8-K on March 21, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's status as of March 21, 2025, and its principal executive offices located in Tucson, Arizona.
Why It Matters
This filing provides investors with crucial updates on Accelerate Diagnostics' financial health and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Accelerate Diagnostics, Inc. (company) — Registrant
- March 21, 2025 (date) — Date of Report
- Tucson, Arizona (location) — Principal Executive Offices
- 001-31822 (other) — Commission File Number
FAQ
What specific financial statements or exhibits are included in this 8-K filing?
The filing indicates that 'Financial Statements and Exhibits' are included as Item Information, but the specific details of these documents are not provided in the excerpt.
What is the primary purpose of this 8-K filing for Accelerate Diagnostics?
The primary purpose is to report on the company's 'Results of Operations and Financial Condition' and to include 'Financial Statements and Exhibits'.
Where are Accelerate Diagnostics' principal executive offices located?
The principal executive offices are located at 3950 South Country Club Road, Suite 470, Tucson, Arizona, 85714.
What is the Commission File Number for Accelerate Diagnostics?
The Commission File Number for Accelerate Diagnostics is 001-31822.
When was the earliest event reported in this filing?
The earliest event reported is dated March 21, 2025, which is also the date of the report.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Accelerate Diagnostics, Inc.